Johnson & Johnson was ordered by a Missouri state jury to pay $72 million of damages to the family of a woman whose death from ovarian cancer was linked to her use of the company's talc-based Baby Powder and Shower to Shower for several decades.

In a verdict announced late Monday night, jurors in the circuit court of St. Louis awarded the family of Jacqueline Fox $10 million of actual damages and $62 million of punitive damages, according to the family's lawyers and court records.

The verdict is the first by a U.S. jury to award damages over the claims, the lawyers said.

Johnson & Johnson faces claims that it, in an effort to boost sales, failed for decades to warn consumers that its talc-based products could cause cancer. About 1,000 cases have been filed in Missouri state court, and another 200 in New Jersey.

Fox, who lived in Birmingham, Alabama, claimed she used Baby Powder and Shower to Shower for feminine hygiene for more than 35 years before being diagnosed three years ago with ovarian cancer. She died in October at age 62.

Jurors found Johnson & Johnson liable for fraud, negligence and conspiracy, the family's lawyers said. Deliberations lasted four hours, following a three-week trial.

Jere Beasley, a lawyer for Fox's family, said Johnson & Johnson "knew as far back as the 1980s of the risk," and yet resorted to "lying to the public, lying to the regulatory agencies." He spoke on a conference call with journalists.

Carol Goodrich, a Johnson & Johnson spokeswoman, said: "We have no higher responsibility than the health and safety of consumers, and we are disappointed with the outcome of the trial. We sympathize with the plaintiff's family but firmly believe the safety of cosmetic talc is supported by decades of scientific evidence."

Trials in several other talc lawsuits have been set for later this year, according to Danielle Mason, who also represented Fox's family at trial.

In October 2013, a federal jury in Sioux Falls, South Dakota found that plaintiff Deane Berg's use of Johnson & Johnson's body powder products was a factor in her developing ovarian cancer. Nevertheless, it awarded no damages, court records show.

Valeant Pharmaceuticals International Inc now owns the Shower to Shower brand but was not a defendant in the Fox case.

The case is Hogans et al v. Johnson & Johnson et al, Circuit Court of the City of St. Louis, Missouri, No. 1422-CC09012.

RELATED: See more of Johnson & Johnson brand products

14 PHOTOS Johnson & Johnson brand products See Gallery J&J must pay $72M for cancer death linked to talcum powder: lawyers Johnson's baby wash is arranged for a photograph in Tiskilwa, Illinois, U.S., on Thursday, July 2, 2015. Johnson & Johnson is expected to report quarterly earnings on July 14, 2015. Photographer: Daniel Acker/Bloomberg via Getty Images Johnson & Johnson Band-Aid brand bandages sit on display in a supermarket in Princeton, Illinois, U.S., on Friday, Oct. 12, 2012. Johnson & Johnson is scheduled to release earnings data on Oct. 16. Photographer: Daniel Acker/Bloomberg via Getty Images Johnson & Johnson (J&J) Listerine brand freshburst mouthwash bottles move through the production line on a conveyor at the J&J consumer healthcare products plant in Lititz, Pennsylvania, U.S., on Wednesday, June 18, 2014. Johnson & Johnson, the world's biggest health-care products company, beat expectations in its first-quarter earnings release in April and raised its 2014 forecast by focusing on new drugs and reducing its reliance on medical devices. J&J is expected to release second-quarter earnings figures on July 15. Photographer: Andrew Harrer/Bloomberg via Getty Images Johnson's baby shampoo is arranged for a photograph in Tiskilwa, Illinois, U.S., on Thursday, July 2, 2015. Johnson & Johnson is expected to report quarterly earnings on July 14, 2015. Photographer: Daniel Acker/Bloomberg via Getty Images Bottles of Johnson's baby powder, produced by Johnson & Johnson, sit on display at a Tesco supermarket in London, U.K., on Tuesday, April 19, 2011. Johnson & Johnson, reeling from more than 50 drug and device recalls since the start of 2010, is trying to recapture its younger self by digesting Synthes Inc. Photographer: Simon Dawson/Bloomberg via Getty Images Johnson & Johnson Neosporin brand ointment sits on display in a supermarket in Princeton, Illinois, U.S., on Friday, Oct. 12, 2012. Johnson & Johnson is scheduled to release earnings data on Oct. 16. Photographer: Daniel Acker/Bloomberg via Getty Images Bottles of Johnson's baby conditioner, produced by Johnson & Johnson, sit on display at a Tesco supermarket in London, U.K., on Tuesday, April 19, 2011. Johnson & Johnson, reeling from more than 50 drug and device recalls since the start of 2010, is trying to recapture its younger self by digesting Synthes Inc. Photographer: Simon Dawson/Bloomberg via Getty Images Johnson & Johnson (J&J) Johnson's brand baby oil bottles move through the production line at the J&J consumer healthcare products plant in Lititz, Pennsylvania, U.S., on Wednesday, June 18, 2014. Johnson & Johnson, the world's biggest health-care products company, beat expectations in its first-quarter earnings release in April and raised its 2014 forecast by focusing on new drugs and reducing its reliance on medical devices. J&J is expected to release second-quarter earnings figures on July 15. Photographer: Andrew Harrer/Bloomberg via Getty Images Johnson & Johnson Band-Aid brand bandages sit on display in a supermarket in Princeton, Illinois, U.S., on Friday, Oct. 12, 2012. Johnson & Johnson is scheduled to release earnings data on Oct. 16. Photographer: Daniel Acker/Bloomberg via Getty Images NEW YORK - OCTOBER 11: Johnson & Johnson, infants? nonprescription cough and cold products are displayed on a shelf at a pharmacy October 11, 2007 in the Brooklyn borough, of New York City. The Consumer Healthcare Products Association announced Thursday that Johnson & Johnson, Wyeth and other manufactures of infants? nonprescription cough and cold products are recalling some medicines in the United States because of the potential danger of overdose. (Photo by Spencer Platt/Getty Images) Johnson & Johnson Neutrogena brand facial soap is arranged for a photograph in Tiskilwa, Illinois, U.S., on Thursday, July 2, 2015. Johnson & Johnson is expected to report quarterly earnings on July 14, 2015. Photographer: Daniel Acker/Bloomberg via Getty Images Johnson & Johnson (J&J) Listerine brand freshburst mouthwash bottles move through the production line on a conveyor at the J&J consumer healthcare products plant in Lititz, Pennsylvania, U.S., on Wednesday, June 18, 2014. Johnson & Johnson, the world's biggest health-care products company, beat expectations in its first-quarter earnings release in April and raised its 2014 forecast by focusing on new drugs and reducing its reliance on medical devices. J&J is expected to release second-quarter earnings figures on July 15. Photographer: Andrew Harrer/Bloomberg via Getty Images Johnson & Johnson Band-Aid brand bandages sit on display in a supermarket in Princeton, Illinois, U.S., on Friday, Oct. 12, 2012. Johnson & Johnson is scheduled to release earnings data on Oct. 16. Photographer: Daniel Acker/Bloomberg via Getty Images UNITED STATES - JANUARY 23: Johnson & Johnson baby oil is arranged on the shelf for an illustration at Skenderian Apothecary in Cambridge, Massachusetts on Tuesday, Jan. 23, 2007. Johnson & Johnson, the world's biggest health-care products company, said profit rose 3.5 percent, led by sales of the Risperdal schizophrenia drug. The shares fell as revenue overall missed analyst expectations. (Photo by Jb Reed/Bloomberg via Getty Images) Up Next See Gallery Discover More Like This HIDE CAPTION SHOW CAPTION of SEE ALL BACK TO SLIDE

More from AOL.com:

Trump's 3rd straight win has rivals looking for answers

Internet rallying behind 97-year-old renter who may get evicted

NASA captures three of Saturn's moons in one stunning image